Dr. Volha Karpava

Dr. Volha Karpava is a medical oncologist at the N.N. Alexandrov National Cancer Centre of Belarus in Minsk, the country's principal oncology institution for cancer diagnosis, treatment, and research. With 17 years of clinical experience, she has developed expertise in breast cancer management and targeted therapy.

The Alexandrov National Cancer Centre is one of the largest oncology centers in the CIS region, providing comprehensive cancer care including surgery, radiation, and medical oncology. Dr. Karpava is a key member of the breast oncology team, participating in multidisciplinary tumor board meetings and clinical research.

She completed advanced oncology training at the N.N. Blokhin National Medical Research Centre of Oncology in Moscow and subsequently undertook ESMO-affiliated continuing education programs. She is committed to implementing international evidence-based oncology guidelines in Belarusian clinical practice.

Dr. Karpava is known for her compassionate approach to patients facing cancer diagnoses and for her dedication to ensuring patients receive clear, understandable information about their treatment options.

Dr. Karpava graduated from the Belarusian State Medical University in Minsk in 2004. She completed her internal medicine and oncology residency at the N.N. Alexandrov National Cancer Centre and undertook advanced oncology training at the N.N. Blokhin National Medical Research Centre of Oncology, Moscow (2009–2010). Her PhD from the Belarusian State Medical University in 2012 focused on neoadjuvant chemotherapy outcomes in locally advanced breast cancer. She is an ESMO member and is certified by the Ministry of Health of Belarus in clinical oncology.

Dr. Karpava's primary clinical focus is breast oncology, with expertise in all stages and subtypes including hormone receptor-positive, HER2-positive, and triple-negative disease. She designs and administers neoadjuvant and adjuvant chemotherapy, HER2-targeted therapy, CDK4/6 inhibitors, and hormone therapy. She also treats ovarian, colorectal, lung cancer, and lymphoma. She participates in multidisciplinary tumor board reviews and integrates molecular pathology results into treatment decision-making.

Dr. Karpava has published over 15 peer-reviewed articles in Belarusian and Russian oncology journals and has contributed to international ESMO-affiliated publications. Her research focuses on neoadjuvant chemotherapy response predictors, HER2-targeted therapy outcomes, and breast cancer epidemiology in Belarus. She collaborates with oncology centers in Russia and participates in CIS oncology research programs.

Dr. Karpava speaks Belarusian, Russian, and English and sees international patients from neighboring countries and the broader CIS region. The Alexandrov National Cancer Centre has experience coordinating care for international patients. Video consultations are available for second opinions and treatment planning reviews. Belarus offers oncology treatment at highly competitive costs.

Dr. Karpava received the Belarusian Society of Oncology Young Investigator Award in 2013. She was recognized by the Alexandrov National Cancer Centre for her contributions to the breast cancer multidisciplinary team program and for her commitment to patient-centered oncology care.